Endogenous Nitric Oxide in Cardiovascular Disease and Transplantation

References

• Moncada S, Palmer R M, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42
   PubMed Web of Science ®Google Scholar
• Kuo L, Davis M J, Chilian W M. Endothelial modulation of arteriolar tone. News Physiol Sci 1992; 7: 5–9
   Google Scholar
• Förstermann U, Nakane M, Tracey W, Pollock J. Isoforms of nitric oxide synthase: functions in the cardiovascular system. Eur Heart J 1993; 14(Suppl 1)10–5
   PubMedGoogle Scholar
• Vanhoutte P M. Other endothelium-derived vasoactive factors. Circulation 1993; 87(Suppl V)V9–17
   Google Scholar
• Weston A H, Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol 1992; 43: 47–54
   PubMed Web of Science ®Google Scholar
• Challinor-Rogers J L, McPherson G A. Potassium channel openers and other regulators of KATP channels. Clin Exp Pharmacol Physiol 1994; 21: 583–97
   Google Scholar
• Tare M, Parkington H, Coleman H A, Neild T, Dusting G. Nitric oxide hyperpolarizes arterial smooth muscle. J Cardiovasc Pharmacol 1991; 17: S108–10
   PubMed Web of Science ®Google Scholar
• Tare M, Parkington H, Coleman H, Neiid T, Dusting G. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 1990; 346: 69–71
   PubMed Web of Science ®Google Scholar
• Ialenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211: 177–82
   PubMed Web of Science ®Google Scholar
• Ralevic V, Khalil Z, Dusting G, Helme R. Nitric oxide contributes to substance P-induced inflammation in rat skin microvasculature. The Biology of Nitric Oxide, S Moncada, M Marietta, J Hibbs, E Higgs. Portland Press, London 1992; Vol. 1: 206–8
   Google Scholar
• Hughes S R, Williams T J, Brain S D. Evidence that endogenous nitric oxide mondulates oedema formation induced by substance P. Eur J Pharmacol 1990; 191: 481–4
   PubMed Web of Science ®Google Scholar
• Ralevic V, Khalil Z, Dusting G, Helme R. Nitric oxide and sensory nerves are involved in the vasodilator response to acetylcholine but not calcitonin gene-related peptide in rat skin microvasculature. Br J Pharmacol 1992; 106: 650–5
   Google Scholar
• Grace G, Dusting G, Kemp B, Martin T. Endothelium and the vasodilator action of rat calcitonin gene-related peptide (CGRP). Br J Pharmacol 1987; 91: 729–33
   PubMed Web of Science ®Google Scholar
• Khalil Z, Ralevic V, Bassirat M, Dusting G, Helme R. Effects of aging on sensory nerve function in rat skin. Brain Res 1994; 641: 265–72
   PubMed Web of Science ®Google Scholar
• Hibbs J B, Jr, Taintor R R, Vavrin Z, . Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. Nitric Oxide from L-Arginine: A Bioregulatory System, S Moncada, E Higgs, et al. Elsevier, Amsterdam 1992; 189–223
   Google Scholar
• Moncada S, Palmer R M, Higgs E A. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol 1989; 38: 1709–15
   PubMed Web of Science ®Google Scholar
• Rubanyi G M, Vanhoutte P M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250: H822–7
   PubMed Web of Science ®Google Scholar
• Beckman J S, Beckman T W, Chen J, Marshall P A, Freeman B A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 17: 1620–4
   Google Scholar
• Ischiropolous H, Zhu L, Beckman J S. Peroxynitrite formation from macrophages-derived nitric oxide. Arch Biochem Biophys 1992; 298: 446–51
   Google Scholar
• Lucchesi B, Mullane K. Leucocytes and ischaemia-induced myocardial injury. Annu Rev Pharmacol Toxicol 1986; 26: 201–4
   PubMed Web of Science ®Google Scholar
• Ku D D. Coronary vascular reactivity after acute myocardial ischaemia. Science 1982; 218: 576–8
   PubMed Web of Science ®Google Scholar
• Sobey C, Dusting G, Grossman H, Woodman O. Impaired vasodilatation of epicardial coronary arteries and resistance vessels following myocardial ischaemia and reperfusion in anaesthetized dogs. Coron Artery Dis 1990; 1: 363–73
   Google Scholar
• Ohlstein E, Nichols A. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res 1989; 65: 917–24
   Google Scholar
• Sessa W, Mullane K. Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro. Br J Pharmacol 1990; 99: 553–9
   PubMed Web of Science ®Google Scholar
• Sobey C, Dusting G J, Stewart A, Woodman O. Rabbit polymorphonuclear leucocytes cause endothelium-dependent contraction of rabbit aorta. J Vase Med Biol 1990; 2: 107–15
   Google Scholar
• Sobey C, Dusting G J, Stewart A. Tumour necrosis factor α augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes. J Cardiovasc Pharmacol 1992; 20: 813–9
   Google Scholar
• Ludmer P, Selwyn A, Shook T, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046–51
   PubMed Web of Science ®Google Scholar
• McFadden E, Bauters C, Lablanche J, Quandalle P, Leroy F, Bertrand M. Response of human coronary arteries to serotonin after injury by coronary angioplasty. Circulation 1993; 88: 2076–85
   Google Scholar
• Drexler H, Zeiher A, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546–50
   PubMed Web of Science ®Google Scholar
• Förstermann U, Mugge A, Alheid U, Haverich A, Frolich J. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988; 62: 185–90
   PubMed Web of Science ®Google Scholar
• Zeiher A, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circ Res 1991; 83: 391–401
   Google Scholar
• Werns S, Walton J, Hsia H, Nabel E, Sanz M, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989; 79: 287–91
   PubMed Web of Science ®Google Scholar
• Chester A, O'Neill G, Moncada S, Tadjkarimi S, Yacoub M. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990; 336: 897–900
   PubMed Web of Science ®Google Scholar
• Verbeuren T, Jordaens F, Van Hove C, Van Hoydonck A, Herman A. Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta. Eur J Pharmacol 1990; 191: 173–8
   PubMed Web of Science ®Google Scholar
• Chowienczyk P, Watts G, Cockcroft J, Ritter J. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet 1992; 340: 1430–2
   PubMed Web of Science ®Google Scholar
• Creager M, Cooke J, Mendelsohn M, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolaemic humans. J Clin Invest 1990; 86: 228–34
   PubMed Web of Science ®Google Scholar
• Chin J PF, Dart A. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects. Effects of fish oils. Clin Exp Pharmacol Physiol 1994; 21: 749–55
   PubMed Web of Science ®Google Scholar
• Osborne J, Lento P, Siegfried M, Stahl G, Fusman B, Lefer A. Cardiovascular effects of acute hyper cholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest 1989; 83: 465–73
   PubMed Web of Science ®Google Scholar
• Leung W, Lau C, Wong C. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993; 341: 1496–500
   PubMed Web of Science ®Google Scholar
• Chin J PF, Dart A. How do fish oils affect vascular function?. Clin Exp Pharmacol Physiol 1995; 22: 71–81
   PubMed Web of Science ®Google Scholar
• Sreeharan N, Jayakody R L, Senaratne M P, Thomson A B, Kappagoda C T. Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta. Can J Physiol Pharmacol 1986; 64: 1451–3
   PubMed Web of Science ®Google Scholar
• Verbeuren T, Jordaens F, Zonnekeyn L, Van Hove C, Coene M-C, Herman A. Effect of hypercholesterolemia on vascular reactivity in the rabbit: endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res 1986; 58: 522–64
   Google Scholar
• Dusting G J, Curcio A, Harris P J, Lima B, Zambetis M, Martin J F. Supersensitivity to vasoconstrictor action of serotonin precedes development of atheroma-like lesions in the rabbit. J Cardiovasc Pharmacol 1990; 16: 667–74
   Google Scholar
• Arthur J, Dusting G. Selective endothelial dysfunction in early atheroma-like lesions in the rabbit. Coron Artery Dis 1992; 3: 623–9
   Web of Science ®Google Scholar
• De Meyer G, Bult H, Van Hoydonck A-E, Jordaens F, Buyssens N, Herman A. Neointima formation impairs endothelial muscarinic receptors while enhancing prostacyclin-mediated responses in the rabbit carotid artery. Circ Res 1991; 68: 1669–80
   Google Scholar
• Booth R, Martin J, Honey A, Beesley J, Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989; 76: 257–68
   PubMed Web of Science ®Google Scholar
• Rubanyi G M. Vascular effects of oxygen-derived free radicals. Free Rad Biol Med 1988; 4: 107–20
   PubMed Web of Science ®Google Scholar
• Henning B, Chow C. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Rad Biol Med 1988; 4: 99–106
   PubMed Web of Science ®Google Scholar
• Chilian W, Dellsperger K, Layne S, et al. Effects of atherosclerosis on the coronary microcirculation. Am J Physiol 1990; 258: H529–39
   PubMed Web of Science ®Google Scholar
• Sellke F, Armstrong M, Harrison D. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 1990; 81: 1586–93
   PubMed Web of Science ®Google Scholar
• Arthur J, Dusting G, Woodman O. Impaired vasodilator function of nitric oxide associated with developing neointima in conscious rabbits. J Vase Res 1994; 31: 187–94
   PubMed Web of Science ®Google Scholar
• Barrett M, Willis A, Vane J. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). Agents Actions 1989; 27: 488–91
   PubMedGoogle Scholar
• Garg U, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphage inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774–7
   PubMed Web of Science ®Google Scholar
• Kariya K, Kawahara Y, Anki S, Fukuzaki H, Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1989; 80: 143–7
   PubMed Web of Science ®Google Scholar
• Assender J, Southgate K, Newby A. Does nitric oxide inhibit smooth muscle proliferation?. J Cardiovasc Pharmacol 1991; 17: S104–7
   Google Scholar
• Schini V, Durante W, Elizondo E, et al. The induction of nitric oxide synthase activity in inhibited by TGF-β1, PDGFαβ and PDGFββ in vascular smooth muscle cells. Eur J Pharmacol 1992; 216: 379–83
   PubMed Web of Science ®Google Scholar
• Jessup W, Mohr D, Gieseg S, Dean R, Stocker R. The participation of nitric oxide in cell-free and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim Biophys Acta 1992; 1180: 73–82
   PubMed Web of Science ®Google Scholar
• Girerd X, Hirsch A, Cooke J, Dzau V, Creager M. L-arginine endothelium-dependent vasodilation in cholesterol rabbits. Circ Res 1990; 67: 1301–8
   PubMed Web of Science ®Google Scholar
• Rossitch E, Alexander E, Black P, Cooke J. L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Clin Invest 1991; 87: 1295–9
   PubMed Web of Science ®Google Scholar
• Jeresich M, Munzel T, Just H, Drexler H. Reduced plasma L-arginine in hypercholesterolaemia. Lancet 1992; 339: 561
   Google Scholar
• Pasini L, Frigerio C, De Giorgi L, Blardi P, Perri T. L-arginine concentrations in hypercholesterolaemia. Lancet 1992; 340: 549
   Google Scholar
• Olebsky D A, Penney M D, Firoozmand S. Serum L-arginine in hypercholesterolaemia. Lancet 1992; 340: 487
   Google Scholar
• Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991; 81: 695–700
   Google Scholar
• Shimokawa H, Vanhoutte P. Dietary cod-liver improves endothelium-dependent response in hypercholesterolaemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421–30
   PubMed Web of Science ®Google Scholar
• Vekshtein V, Yeung A, Vita J, et al. Fish oil improves endothelium-dependent relaxation in patients with coronary artery disease. Circulation 1989; 80(Suppl II)11–434
   Google Scholar
• Fleischhauer F, Yan W-D, Fischell T. Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients. J Am Coll Cardiol 1993; 21: 982–9
   PubMed Web of Science ®Google Scholar
• Powell J, Clozel J-P, Muller K, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186–8
   PubMed Web of Science ®Google Scholar
• Farhy R, Ho K, Carretero O, Scicli A. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992; 182: 283–8
   PubMed Web of Science ®Google Scholar
• MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty?. Circulation 1992; 86: 100–10
   PubMed Web of Science ®Google Scholar
• Becker R, Wieme R, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol 1991; 18: S110–5
   Google Scholar
• Chobanian A, Haudenschild Ch C, Nickerson C, Hope S. Anti-atherogenic effect of captopril in the watanabe heritable hyperlipidemic rabbit. Hypertension 1990; 15: 327–31
   PubMed Web of Science ®Google Scholar
• Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 1990; 15: S65–72
   PubMed Web of Science ®Google Scholar
• Dusting G, Makdissi M, Hickey H. Perindopril reduces neo-intima development and partially restores endothelial nitric oxide function in rabbit carotid arteries. Curr Adv ACE Inhibition. 111, (in press)
   Google Scholar
• Dusting G, Hyland R, Hickey H, Makdissi M. ACE inhibitors reduce neo-intimal thickening and maintain endothelial nitric oxide function in rabbit carotid arteries. Am J Cardiol, (in press)
   Google Scholar
• Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Linger T. Vascular modelling in systemic hypertension. Am J Cardiol 1993; 71: 2–7E
   PubMed Web of Science ®Google Scholar
• Dusting G, Macdonald P. Prostacyclin and vascular function: implications for hypertension and atherosclerosis. Pharmacol Ther 1990; 48: 323–44
   PubMedGoogle Scholar
• Kaiser L, Spickard R, Olivier N. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989; 256: H962–7
   Google Scholar
• Drexler H, Lu W. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol 1992; 262: H1640–5
   Google Scholar
• Treasure C, Vita J, Cox D, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990; 81: 772–9
   PubMed Web of Science ®Google Scholar
• Kubo S, Rector T, Bank A, Williams R, Heifetz S. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84: 1589–96
   PubMed Web of Science ®Google Scholar
• O'Murchu B, Miller V, Perella M, Burnett J. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest 1994; 93: 165–71
   PubMed Web of Science ®Google Scholar
• Drexler H, Hayoz D, Munzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992; 69: 1596–601
   PubMed Web of Science ®Google Scholar
• Habib F, Dutka D, Crossman D, Oakley C, Cleland J. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?. Lancer 1994; 344: 371–3
   Google Scholar
• Winlaw D, Smythe G, Keogh A, Schyvens C, Spratt P, Macdonald P. Increased nitric oxide production in heart failure. Lancet 1994; 344: 373–4
   PubMed Web of Science ®Google Scholar
• Levine B, Kalman J, Mayer L, Fillit H, Packer M. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236–41
   PubMed Web of Science ®Google Scholar
• Katz S, Rao R, Berman J, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive cardiac failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 1994; 90: 12–6
   Google Scholar
• McMurray J, Abdullah I, Dargie H, Shapiro D. Increased concentrations of tumour necrosis factor in ‘cachectic’ patients with severe chronic heart failure. Br Heart J 1991; 66: 356–8
   PubMedGoogle Scholar
• Yoshizumi M, Perrella M, Burnett J, Lee M. Tumor necrosis factor downregulates an endothelial nitric oxide synthase messenger RNA by shortening its half-life. Circ Res 1993; 73: 205–9
   PubMed Web of Science ®Google Scholar
• Matsubara T, Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 1986; 137: 3295–8
   PubMed Web of Science ®Google Scholar
• Gross S, Jaffe E, Levi R, Kilbourn R. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 1991; 178: 823–9
   PubMed Web of Science ®Google Scholar
• Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Letts 1990; 275: 87–90
   PubMed Web of Science ®Google Scholar
• De Belder A, Radomski M, Why H, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993; 341: 84–5
   PubMed Web of Science ®Google Scholar
• Finkel M, Oddis C, Jacob T, Watkins S, Hattler B, Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–9
   PubMed Web of Science ®Google Scholar
• Balligand J, Ungureanu D, Kelly R, et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993; 91: 2314–9
   PubMed Web of Science ®Google Scholar
• Shah A, Smith J, Lewis M. The role of endocardium in the modulation of contraction of isolated papillary muscles of the ferret. J Cardiovasc Pharmacol 1991; 17: S251–7
   PubMed Web of Science ®Google Scholar
• Packer M. The development of positive inotropic agents for chronic heart failure: how have we gone astray?. J Am Coll Cardiol 1993; 22(4 Suppl A)119–26A
   Google Scholar
• Waagstein F, Bristow M, Swedberg K, et al. Beneficial effects of metoprolol in dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993; 342: 1441–6
   PubMed Web of Science ®Google Scholar
• Paulus W, Vantrimpont P, Shah A. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation 1994; 89: 2070–8
   PubMed Web of Science ®Google Scholar
• Schoelkens B, Linz W. Bradykinin-mediated metabolic effects in isolated perfused rat hearts. Agents Actions 1992; 38(Suppl. II)36–42
   Google Scholar
• Vegh A, Szekeres L, Parratt J. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 1992; 107: 648–52
   PubMed Web of Science ®Google Scholar
• Langrehr J, Hoffman R, Lancaster J, Simmons R. Nitric oxide—a new endogenous immunovasodilator. Transplantation 1993; 55: 1205–12
   PubMed Web of Science ®Google Scholar
• Akita K, Dusting G, Hickey H. Cyclosporin A and FK 506 suppress nitric oxide production by a murine macrophage cell line J774 and rat vascular smooth muscle cells. The Biology of Nitric Oxide, S Moncada, M Feelisch, R Busse, E Higgs. Portland Press, London 1994; Vol. 4: 479–84
   Google Scholar
• Akita K, Dusting G, Hickey H. Suppression of nitric oxide production by Cyclosporin A and FK 506 in rat vascular smooth muscle cells. Clin Exp Pharmacol Physiol 1994; 21: 231–3
   Google Scholar
• Ryffel B. Pharmacology of cyclosporine. Pharmacol Rev 1989; 41: 407–22
   Web of Science ®Google Scholar
• Dawson T M, Steiner J P, Dawson V L, Dinerman J L, Uhl J R, Snyder S H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 9808–12
   PubMed Web of Science ®Google Scholar
• Akita K, Dusting G. Cyclosporin A and FK 506 suppress vasodilator nitric oxide in vascular smooth muscle. Agents Actions, (in press)
   Google Scholar
• Kroncke K D, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 1991; 175: 752–8
   Google Scholar
• Canadian European Diabetes Study Group. Cyclosporin-induced remission of IDDM after early intervention. Diabetes 1988; 37: 1574–82
   Google Scholar
• Seifter E, Rettura G, Levenson S, Barbul A. Supplemental arginine and ornithine promote allograft rejection. Abstracts 183rd Mtg Am Chem Soc. Am Chem Soc, Las Vegas, NV 1982, AGFD-11
   Google Scholar
• Winlaw D, Schyvens C, Smythe G, et al. Urinary nitrate excretion is a non-invasive indicator of acute cardiac allograft rejection and nitric oxide production in the rat. Transplantation, (in press)
   Google Scholar
• Winlaw D, Schyvens C, Smythe G, et al. Selective inhibition of NO production during cardiac allograft rejection causes a small increase in graft survival. Transplantation, (in press)
   Google Scholar
• Yang X, Chowdhury N, Brett J, Marboe C, Sciacca R, Michler R. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994; 94: 714–21
   PubMed Web of Science ®Google Scholar
• Ding A, Nathan C, Stuehr D. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 1988; 141: 2407–12
   PubMed Web of Science ®Google Scholar
• Chan S, Kobashigawa J, Stevenson L, Brownfield E, Brunken R, Schelbert H. Myocardial blood flow at rest and during pharmacological vasodilation in cardiac transplants during and after successful treatment of rejection. Circulation 1994; 90: 204–12
   PubMed Web of Science ®Google Scholar
• Valantine H, Yeoh T, Gibbons R, et al. Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. J Heart Lung Transplant 1991; 10: 757–65
   Google Scholar
• Evans H, Lewis M, Shah A. lnterleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc Res 1993; 27: 1486–90
   PubMed Web of Science ®Google Scholar
• Lancaster J, Langrehr J, Bergonia H, Murase N, Simmons R, Hoffman R. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 1992; 267: 10994–8
   PubMed Web of Science ®Google Scholar
• Bulgrin J, Shabani M, Smith D. Arginine-free diet suppresses nitric oxide production in wounds. J Nutr Biochem 1993; 4: 588–93
   Google Scholar
• Barbul A. Physiology and pharmacology of arginine. Nitric Oxide from L-arginine: A Bioregulatory System, S Moncada, E A Higgs. Elsevier, Amsterdam 1990; 317–29
   Google Scholar
• Wilner M, Ettenger R, Koyle M, Rosenthal J. The effect of hypoprolactinemia alone and in combination with cyclosporine on allograft rejection. Transplantation 1990; 49: 264–7
   PubMedGoogle Scholar
• Hibbs J, Taintor R, Vavrin Z, Rachlin E. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87–94
   PubMed Web of Science ®Google Scholar
• Langrehr J, White D, Hoffman R, Simmons R. Macrophages produce nitric oxide at allograft sites. Ann Surg 1993; 218: 159–66
   Google Scholar
• Langrehr J, Dull K, Ochoa J, et al. Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 1992; 53: 632–40
   Google Scholar